CYTK – cytokinetics, incorporated (US:NASDAQ)
Stock Stats
News
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
Cytokinetics Announces Positive CHMP Opinion of MYQORZO® (Aficamten) for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Notice For Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf
Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
Form 8-K CYTOKINETICS INC For: Dec 12
Form 4 CYTOKINETICS INC For: Dec 08 Filed by: Callos Andrew
Form 4 CYTOKINETICS INC For: Dec 05 Filed by: Callos Andrew
Form 144 CYTOKINETICS INC Filed by: Callos Andrew
Form 4 CYTOKINETICS INC For: Dec 03 Filed by: Lee Sung
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.